| Dr Jubril Oyekanmi Oyeyemi, MD | |
|
175 Madison Ave, Mount Holly, NJ 08060-2038 | |
| (609) 914-6180 | |
| (609) 914-6182 |
| Full Name | Dr Jubril Oyekanmi Oyeyemi |
|---|---|
| Gender | Male |
| Speciality | Internal Medicine |
| Experience | 15 Years |
| Location | 175 Madison Ave, Mount Holly, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003050022 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | MD446405 (Pennsylvania) | Secondary |
| 207R00000X | Internal Medicine | 25MA09168400 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Virtua West Jersey Hospitals | Voorhees, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virtua Medical Group, Pa | 9830222397 | 1226 |
News Archive
XenoPort, Inc. announced today that the European Patent Office (EPO) Opposition Division ruled that the European patent for the composition of matter of XP13512 (European Patent No. 1 404 324) is valid.
Like most other continents, Africa is affected by the novel coronavirus causing COVID-19. African nations are gearing up to curb the spread of the infection by imposing travel bans and lockdowns for the populations. The picture today looks grim, but steps are being taken to address the pandemic in Africa.
Epigenomics AG, the German-American cancer molecular diagnostics company, has announced that the U.S. Food and Drug Administration (FDA) has approved the Company's lead product, Epi proColon®, the first and only FDA-approved blood-based colorectal cancer screening test.
University of Hawaii at Manoa assistant researcher Durrell Kapan recently published a paper, Man Bites Mosquito: Understanding the Contribution of Human Movement to Vector-Borne Disease Dynamics, in PLoS One. Published August 26, the paper highlights how daily commuting patterns in mega-cities may be a critically overlooked factor in understanding the resurgence of mosquito-borne diseases such as dengue fever, infecting 50-100 million people annually.
The metabolic syndrome, a group of several abnormalities, including obesity and high blood pressure, in one individual was identified in 10.4 percent of 36-year-old study participants, according to an article in the January 10 issue of Archives of Internal Medicine.
› Verified 6 days ago
| Entity Name | Virtua Medical Group, Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1649226515 PECOS PAC ID: 9830222397 Enrollment ID: O20100804000338 |
News Archive
XenoPort, Inc. announced today that the European Patent Office (EPO) Opposition Division ruled that the European patent for the composition of matter of XP13512 (European Patent No. 1 404 324) is valid.
Like most other continents, Africa is affected by the novel coronavirus causing COVID-19. African nations are gearing up to curb the spread of the infection by imposing travel bans and lockdowns for the populations. The picture today looks grim, but steps are being taken to address the pandemic in Africa.
Epigenomics AG, the German-American cancer molecular diagnostics company, has announced that the U.S. Food and Drug Administration (FDA) has approved the Company's lead product, Epi proColon®, the first and only FDA-approved blood-based colorectal cancer screening test.
University of Hawaii at Manoa assistant researcher Durrell Kapan recently published a paper, Man Bites Mosquito: Understanding the Contribution of Human Movement to Vector-Borne Disease Dynamics, in PLoS One. Published August 26, the paper highlights how daily commuting patterns in mega-cities may be a critically overlooked factor in understanding the resurgence of mosquito-borne diseases such as dengue fever, infecting 50-100 million people annually.
The metabolic syndrome, a group of several abnormalities, including obesity and high blood pressure, in one individual was identified in 10.4 percent of 36-year-old study participants, according to an article in the January 10 issue of Archives of Internal Medicine.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Jubril Oyekanmi Oyeyemi, MD 40 Lake Ctr, 401 Route 73 N Suite 201a, Marlton, NJ 08053-3425 Ph: (856) 355-0340 | Dr Jubril Oyekanmi Oyeyemi, MD 175 Madison Ave, Mount Holly, NJ 08060-2038 Ph: (609) 914-6180 |
News Archive
XenoPort, Inc. announced today that the European Patent Office (EPO) Opposition Division ruled that the European patent for the composition of matter of XP13512 (European Patent No. 1 404 324) is valid.
Like most other continents, Africa is affected by the novel coronavirus causing COVID-19. African nations are gearing up to curb the spread of the infection by imposing travel bans and lockdowns for the populations. The picture today looks grim, but steps are being taken to address the pandemic in Africa.
Epigenomics AG, the German-American cancer molecular diagnostics company, has announced that the U.S. Food and Drug Administration (FDA) has approved the Company's lead product, Epi proColon®, the first and only FDA-approved blood-based colorectal cancer screening test.
University of Hawaii at Manoa assistant researcher Durrell Kapan recently published a paper, Man Bites Mosquito: Understanding the Contribution of Human Movement to Vector-Borne Disease Dynamics, in PLoS One. Published August 26, the paper highlights how daily commuting patterns in mega-cities may be a critically overlooked factor in understanding the resurgence of mosquito-borne diseases such as dengue fever, infecting 50-100 million people annually.
The metabolic syndrome, a group of several abnormalities, including obesity and high blood pressure, in one individual was identified in 10.4 percent of 36-year-old study participants, according to an article in the January 10 issue of Archives of Internal Medicine.
› Verified 6 days ago
Sharon Franklin Castellino, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Jyothi Jagadeesh, M.D Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Amara Nidimusili, Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6000 Fax: 609-914-6182 | |
Dr. Caroline Michelle Ropiak, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6000 | |
Dr. Michael A Lawandy, D.O. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Dr. Sabeeha Nisar, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6180 Fax: 609-914-6182 | |
Shahjahan Nisar Chaudhry, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 175 Madison Ave, Mount Holly, NJ 08060 Phone: 609-914-6000 Fax: 609-914-6182 |